Bevacizumab (B), cisplatin and vinorelbine in chemo-naive patients (P) with non squamous non small cell lung cancer (NSCLC): a galician lung cancer group phase II study

被引：0
|
作者：
Vazquez, S. [1 ]
Leon, L. [2 ]
Gracia, J. M. [3 ]
Casal, J. [4 ]
Lazaro, M. [5 ]
Firvida, J. L. [6 ]
Amenedo, M. [7 ]
Santome, L. [8 ]
Cardona, J. V. [9 ]
Macia, S. [10 ]
机构：
[1] Complexo Hosp Xeral Calde, Lugo, Spain
[2] Complexo Hosp Univ Santiago, Santiago De Compostela, Spain
[3] Hosp Cabuenes, Gijon, Spain
[4] Complexo Hosp Univ Vigo Hosp Do Meixoeiro, Vigo, Spain
[5] Complexo Hosp Univ Vigo Hosp Xeral Cies, Vigo, Spain
[6] Complexo Hosp Ourense, Orense, Spain
[7] Ctr Oncol Galicia, La Coruna, Spain
[8] Hosp POVISA, Vigo, Spain
[9] Roche Farma SA, Madrid, Spain
[10] Hosp Gen Elda, Elda, Spain
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 02期
关键词：
D O I：
10.1016/S1359-6349(09)71858-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：548 / 549
页数：2
相关论文
共 50 条
  • [41] Oral S-1 and carboplatin plus bevacizumab with maintenance S-1 and bevacizumab for chemo-naive patients (Pts) with advanced non-squamous non-small cell lung cancer (NSCLC).
    Kaneda, Hiroyasu
    Urata, Yoshiko
    Okamoto, Isamu
    Hattori, Yoshihiro
    Okuno, Keiko
    Shimada, Temiko
    Takeda, Masayuki
    Kurata, Takayasu
    Miyazaki, Masaki
    Terashima, Masaaki
    Tanaka, Kaoru
    Kiyota, Hidemi
    Hayashi, Hidetoshi
    Kudo, Toshihiro
    Okabe, Takafumi
    Azuma, Koichi
    Morita, Satoshi
    Nakagawa, Kazuhiko
    Negoro, Shunichi
    Satouchi, Miyako
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [42] A phase I pharmacokinetic study of bexarotene with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancer (NSCLC)
    Heather A. Wakelee
    Gary Middleton
    David Dunlop
    Rodryg Ramlau
    Natasha Leighl
    Desiree Hao
    Arturo Lopez-Anaya
    Petr Zatloukal
    Charlotte D. Jacobs
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 815 - 824
  • [43] A phase I pharmacokinetic study of bexarotene with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancer (NSCLC)
    Wakelee, Heather A.
    Middleton, Gary
    Dunlop, David
    Ramlau, Rodryg
    Leighl, Natasha
    Hao, Desiree
    Lopez-Anaya, Arturo
    Zatloukal, Petr
    Jacobs, Charlotte D.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (03) : 815 - 824
  • [44] Gefitinib in chemo-naive, poor performance status, Non Small Cell Lung Cancer (NSCLC) patients - A randomized, single institution pilot study
    Malhotra, Hemant
    Sharma, Rajesh
    Khandelwal, P. D.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S697 - S698
  • [45] Phase I and pharmacologic study of weekly gemcitabine and paclitaxel in chemo-naive patients with advanced non-small-cell lung cancer
    De Pas, T
    de Braud, F
    Danesi, R
    Sessa, C
    Catania, C
    Curigliano, G
    Fogli, S
    del Tacca, M
    Zampino, G
    Sbanotto, A
    Rocca, A
    Cinieri, S
    Marrocco, E
    Milani, A
    Goldhirsch, A
    ANNALS OF ONCOLOGY, 2000, 11 (07) : 821 - 827
  • [46] CONCURRENT CHEMORADIATION (CCHRT) FOR STAGE III NON-SMALL CELL LUNG CANCER (NSCLC): A PHASE II STUDY FROM THE GALICIAN LUNG CANCER GROUP
    Casal, Joaquin
    Ponte, C.
    Senin, C.
    Campos, B.
    Firvida, Xl
    Carmona, M.
    Hernandez, E.
    Lopez, Md
    Formoso, I.
    Lazaro, M.
    Vazquez, S.
    Areses, Mc
    Rodriguez, C.
    Pena, C.
    Villanueva, Mj
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S849 - S849
  • [47] RANDOMIZED PHASE II TRIAL OF NGR-HTNF AND CHEMOTHERAPY IN CHEMO-NAIVE PATIENTS WITH NON-SMALL CELL LUNG CANCER (NSCLC): PRELIMINARY RESULTS.
    Gregorc, Vanesa
    Zilembo, N.
    Grossi, Francesco
    Rossoni, Gilda
    Pietrantonio, Filippo
    Rijavec, Erika
    Bulotta, Alessandra
    Vitali, Milena
    Barletta, Giulia
    Bergamaschi, Luca
    Platania, Marco
    Lambiase, Antonio
    Bordignon, Claudio
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S661 - S662
  • [48] Erlotinib as maintenance therapy after concurrent chemoradiotherapy in patients (p) with stage III non-small cell lung cancer (NSCLC): A Galician Lung Cancer Group phase II study
    Casal, J.
    Vazquez, S.
    Leon, L.
    Lazaro, M.
    Firvida, J. L.
    Amenedo, M.
    Alonso, G.
    Santome, L.
    Afonso, F. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [49] A Galician Lung Cancer Group phase II study: Erlotinib as maintenance therapy after concurrent chemoradiotherapy in patients (p) with stage III non-small cell lung cancer (NSCLC)
    Vazquez, S.
    Firvida, J.
    Lazaro, M.
    Baron, F. J.
    Alonso-Jaudenes Curbera, G.
    Amenedo, M.
    Santome, L.
    Afonso, F. J.
    Cardona, J. V.
    Casal, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [50] A phase I/II study of cisplatin and vinorelbine chemotherapy in patients with advanced non-small cell lung cancer
    Hotta, K
    Sekine, I
    Tamura, T
    Sawada, M
    Watanabe, H
    Kusaba, H
    Akiyama, Y
    Inoue, A
    Shimoyama, T
    Nokihara, H
    Ueda, Y
    Yamamoto, N
    Kunitoh, H
    Ohe, Y
    Kodama, T
    Saijo, N
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2001, 31 (12) : 596 - 600
12345